1,090 episodes
JACC Specialty Journals American College of Cardiology
-
- Health & Fitness
In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.
-
JACC: Asia - Causal Association of Arterial Stiffness With the Risk of Chronic Kidney Disease
Commentary by Dr Dong Zhao
-
JACC: Asia - Life’s Essential 8 in Relation to Cardiovascular Disease and Mortality in Individuals With Diabetes
Commentary by Dr Steven Ho Man Lam
-
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy
Commentary by Dr. Emile Daoud
-
JACC: CardioOncology Pulse - Cancer Survivorship: The Patient Perspective
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC interviews Steven Petrow, an award-winning journalist and book author, who shares his moving story and personal experiences as a survivor of cancer.
-
JACC: CardioOncology Pulse - Cardio-Oncology in the Older Adult
William Dale, MD, PhD, Supriya Gupta Mohile, MD, MS and Efrat Dotan, MD discuss how to effectively care for older adults with cancer, incuding challenges and opportunities for the field of cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.
-
JACC: CardioOncology Pulse - SGLT2 Inhibitors and Withdrawal of Neurohormonal Therapy in Cancer Therapy-Related Cardiotoxicity: What Is the Evidence?
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Dinesh Thavendiranathan, MD, MSc, Husam Abdel-Qadir, MD, PhD and Christopher Yu, MBBS discuss recent studies of SGLT2 inhibitors and withdrawal of neurhormonal therapy for cancer therapy-related cardiotoxicity.
Top Podcasts In Health & Fitness
You Might Also Like